Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Active not recruiting 4Recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 83Lung Neoplasms 29Neoplasms 7Neoplasm Metastasis 7Carcinoma 5Colorectal Neoplasms 4NSCLC 3Breast Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Non Small Cell Lung Cancer Metastatic 2Multiple Myeloma 2Meningeal Carcinomatosis 2Lymphoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stage II-IIIB Non-small Cell Lung Carcinoma 1Stage IB-IIIA Non-small Cell Lung Carcinoma 1Solid Tumor, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 25Cisplatin 24Carboplatin 19Paclitaxel 16Magnetic Resonance Spectroscopy 16Specimen Handling 14Pemetrexed 12durvalumab 10Radiotherapy, Intensity-Modulated 8Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Nivolumab 7Radiation 6Docetaxel 6Cetuximab 6Biopsy 6osimertinib 5cemiplimab 5Taxes 5Radiotherapy 5Ipilimumab 5Gemcitabine 5Cyclophosphamide 51-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 5poly ICLC 4cabozantinib 4atezolizumab 4Oxaliplatin 4Fluorouracil 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Carcinoma × osimertinib × 1 year × Clear all
NCT06417814 2026-05-14

TROPION-Lung15

AstraZeneca

Phase 3 Recruiting
744 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT03778229 2026-04-23

SAVANNAH

AstraZeneca

Phase 2 Active not recruiting
367 enrolled 32 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05261399 2026-04-06

SAFFRON

AstraZeneca

Phase 3 Active not recruiting
345 enrolled
Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT04606771 2026-02-27

CoC

AstraZeneca

Phase 2 Active not recruiting
30 enrolled 20 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04035486 2025-10-10

FLAURA2

AstraZeneca

Phase 3 Active not recruiting
587 enrolled 44 charts 1 FDA
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡